These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2316912)

  • 41. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats.
    Eltom SE; Guard CL; Schwark WS
    J Vet Pharmacol Ther; 1993 Jun; 16(2):141-51. PubMed ID: 8345564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of phenylbutazone and oxyphenabutazone in the pig.
    Hvidberg EF; Rasmussen F
    Can J Comp Med; 1975 Jan; 39(1):80-8. PubMed ID: 234284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Competitive binding to plasma thyroid hormone transport proteins and thyroid disruption by phenylbutazone used as a probe.
    Gayrard V; Picard-Hagen N; Viguié C; Toutain PL
    Gen Comp Endocrinol; 2011 Nov; 174(2):225-31. PubMed ID: 21933675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
    Authie EC; Garcia P; Popot MA; Toutain PL; Doucet M
    Equine Vet J; 2010 Apr; 42(3):240-7. PubMed ID: 20486981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-dependent pharmacokinetics of phenylbutazone in calves.
    Volner Z; Nouws JF; Kozjek F; van Ginneken CA; Primozic S
    Vet Q; 1990 Apr; 12(2):98-102. PubMed ID: 2363243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of phenylbutazone on bone activity and formation in horses.
    Rohde C; Anderson DE; Bertone AL; Weisbrode SE
    Am J Vet Res; 2000 May; 61(5):537-43. PubMed ID: 10803649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.
    Toutain PL; Autefage A; Legrand C; Alvinerie M
    J Vet Pharmacol Ther; 1994 Dec; 17(6):459-69. PubMed ID: 7707492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses.
    Toutain PL; Lassourd V; Costes G; Alvinerie M; Bret L; Lefebvre HP; Braun JP
    J Vet Pharmacol Ther; 1995 Jun; 18(3):226-35. PubMed ID: 7674460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of phenylbutazone in beef steers.
    de Veau IF; Pedersoli W; Cullison R; Baker J
    J Vet Pharmacol Ther; 2002 Jun; 25(3):195-200. PubMed ID: 12081615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of pharmacodynamic and pharmacokinetic interactions between acetohexamide and phenylbutazone in rabbits.
    Imamura Y; Nomura T; Katsuki Y; Kojima Y; Otagiri M
    Pharmacol Toxicol; 1990 Nov; 67(5):415-9. PubMed ID: 2096386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary studies of offspring exposure to phenylbutazone and ivermectin during the perinatal period in a Holstein cow-calf model.
    Chamberlain PL; Fowler BA; Sexton MJ; Peggins JO; Bredow Jv
    Toxicol Appl Pharmacol; 2003 Mar; 187(3):198-208. PubMed ID: 12662903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses.
    Knych HK; Stanley SD; Seminoff KN; McKemie DS; Kass PH
    J Vet Pharmacol Ther; 2016 Oct; 39(5):469-77. PubMed ID: 26924025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous and minimally invasive assessment of muscle tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals.
    Ferre PJ; Laroute V; Braun JP; Cazaux J; Toutain PL; Lefebvre HP
    J Anim Sci; 2006 May; 84(5):1295-301. PubMed ID: 16612034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses.
    Sabaté D; Homedes J; Salichs M; Sust M; Monreal L
    Equine Vet J; 2009 Sep; 41(7):700-5. PubMed ID: 19927590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.